Browse the full record of transactions filed by Weiss Michael S, 首席执行官. Director active across 4 companies, notably Checkpoint Therapeutics, Inc.. In total, 29 filings have been logged. Split: 3 buys · 0 sell. Total volume traded: €2.1m. Activity tracked since 10 June 2021. The latest transaction was filed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Weiss Michael S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
WEISS MICHAEL S is Directeur Général and appears in 29 filings in total. Across the 29 sampled filings, the recorded activity consists of buys only, for a total of EUR 2086951, with no sells, and the observed period runs from 2016-01-04 to 2026-03-20. He is listed at TG Therapeutics, INC., Fortress Biotech, Inc., Checkpoint Therapeutics, Inc., and Mustang Bio, INC.